We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BIO market cap is 10.06B. The company's latest EPS is USD -22.7642 and P/E is -15.71.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 632.12M | 681.18M | 610.82M | 638.48M | 649.73M |
| Operating Income | 90.95M | 95.32M | 44.71M | 101.5M | 64.47M |
| Net Income | -476.67M | 932.64M | 383.92M | -2.17B | 653.17M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.31B | 2.55B | 2.92B | 2.8B | 2.67B |
| Operating Income | 229.66M | 410.96M | 489.43M | 475.12M | 337.8M |
| Net Income | 1.76B | 3.81B | 4.25B | -3.63B | -637.32M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.9B | 12.3B | 12.61B | 9.69B | 10.6B |
| Total Liabilities | 3.48B | 3.56B | 3.56B | 2.91B | 3.12B |
| Total Equity | 8.42B | 8.74B | 9.05B | 6.78B | 7.49B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.01B | 12.97B | 17.78B | 13.5B | 12.3B |
| Total Liabilities | 2.25B | 3.09B | 4.11B | 3.89B | 3.56B |
| Total Equity | 5.76B | 9.88B | 13.67B | 9.62B | 8.74B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 293.9M | 374.9M | 69.79M | 167.44M | 331.05M |
| Investing | -51.99M | 20.21M | -43.09M | -74.02M | -129.66M |
| Financing | -225.03M | -425.65M | 21k | -96.57M | -192.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 457.9M | 575.33M | 656.52M | 194.45M | 374.9M |
| Investing | -208.89M | -60.25M | -784.44M | -1.21B | 20.21M |
| Financing | -22.76M | -523.04M | -55.43M | 973.58M | -425.65M |
| Market Cap | 10.06B |
| Price to Earnings Ratio | -15.71 |
| Price to Sales Ratio | 3.75 |
| Price to Cash Ratio | 24.8 |
| Price to Book Ratio | 1.15 |
| Dividend Yield | - |
| Shares Outstanding | 28M |
| Average Volume (1 week) | 153.42k |
| Average Volume (1 Month) | 148.65k |
| 52 Week Change | 8.77% |
| 52 Week High | 386.54 |
| 52 Week Low | 262.01 |
| Spread (Intraday) | 0.82 (0.23%) |
| Company Name | Bio Rad Laboratories Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bio-rad.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
